Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Mar 08, 2010 9:11am
240 Views
Post# 16854708

Market orders

Market ordersOverall, these small market sell/buy orders probably mean nothing, but I feel that they try to set the tone, or at least my morning mood.
     CUR should gap up this morning but we continue to have some ASK orders at $1.20 that we need to take care of. There was a small early morning buy at this price but it was pulled and now we have a market sell at $1.16. Give me a break. Stock moved to $2.40 when Kramer spoke about pca3 on his show, and here we are with the trial we have waited for, stuck at 1.19.
     In the past, stocks that I have owned, I at least had a good feeing on how they would respond to news. This is not but the rumor sell the news because there was never any buying,
     I am still looking for run to $1.50 and us hitting $2 in the very short term. (remember we were at $3.17 prior to market sell off)
Diagnocure was also at a colon cancer conf in St. Louis over the weekend. For now pca3 is the ticket, with what I would expect, a very quick FDA approval process. GCC will catch on and we need them to get moving on the blood test because it will get them in the door.
Bullboard Posts